 SOUTH SAN FRANCISCO, Calif., Sept. 13, 2021 GLOBE NEWSWIRE -- Day One Biopharmaceuticals Nasdaq: DAWN, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers, today announced the appointment of Jaa Roberson as chief people officer. In her role, Ms. Roberson will oversee all aspects of Day Ones human resources and talent acquisition efforts. 